MedImmune, LLC, a subsidiary of AstraZeneca, is a leading biotechnology company headquartered in the United States. Founded in 1988, MedImmune has established itself as a key player in the biopharmaceutical industry, focusing on the development of innovative therapies for respiratory, oncology, and infectious diseases. With major operational regions across North America and Europe, MedImmune is renowned for its pioneering work in monoclonal antibodies and biologics. The company’s flagship products, including Synagis and FluMist, are distinguished by their unique mechanisms of action and significant clinical impact. MedImmune's commitment to research and development has positioned it as a market leader, achieving notable milestones such as the successful launch of groundbreaking therapies that address unmet medical needs. Through its dedication to advancing science and improving patient outcomes, MedImmune continues to shape the future of healthcare.
We don't have data for MedImmune, LLC, but we can show you information about their parent organization instead.
View parent company